论文部分内容阅读
目的探讨中心静脉导管胸腔内留置并胸腔内注射尿激酶在结核性渗出性胸膜炎中的应用价值。方法临床诊断的初治结核性渗出性胸膜炎30例,胸腔内置入中心静脉导管,非限量不定时地引流胸水,引流量明显减少或消失后胸腔内注入尿激酶10万～20万单位。结果胸水引流量明显增多,胸膜反应、胸膜粘连、肥厚、包裹性胸腔积液等发生率明显减少。结论中心静脉导管胸腔内留置术并胸腔内注射尿激酶治疗结核性渗出性胸膜炎,方法简便、安全,疗效确切,并发症少,值得临床推广。
Objective To investigate the clinical value of central venous catheters in thoracic cavity and intrapleural injection of urokinase in tuberculous exudative pleurisy. Methods Thirty patients with newly diagnosed tuberculous exudative pleurisy diagnosed clinically were treated with central venous catheterization in the thoracic cavity. The pleural effusion was induced in a non-limited and irregular manner. The drainage volume was significantly reduced or disappeared, and the urokinase was injected into the thoracic cavity at 100,000 to 200,000 units. Results Pleural effusion increased significantly, pleural reaction, pleural adhesions, hypertrophy, encapsulated pleural effusion and other incidence was significantly reduced. Conclusion Central venous catheter pleural indwelling intrapleural injection of urokinase in the treatment of tuberculous exudative pleurisy, the method is simple, safe, effective, less complications, is worthy of clinical promotion.